Effects of Emotion on Episodic Memory in Typically Developing Children and Children With Williams-Beuren Syndrome
EEM-TAdev
1 other identifier
interventional
280
1 country
1
Brief Summary
It's well established in the literature that emotional events are more likely to be remembered than neutral events. Although this Emotional Enhancement of Memory (EEM) has been well demonstrated in the adult literature, little is known about EEM for typically developing children and children with Williams-Beuren syndrome (WBS). In this study, two investigations will be conducted concomitantly: one of EEM in typically developing children and the other of EEM in children with WBS. For this purpose, three behavioral experiments will be established to investigate EEM in this two populations, with the first experiment also including electroencephalography measures. Performances of typically developing children will be compared to young adults, and performances of children with WBS will be compared to control children matched for mental age. Finally, this study aims to bring new knowledge about the interactions between emotion and memory in children, and to better understand cognitive functioning in children with WBS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 28, 2018
CompletedFirst Submitted
Initial submission to the registry
July 2, 2018
CompletedFirst Posted
Study publicly available on registry
September 28, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2020
CompletedFebruary 9, 2021
February 1, 2021
2.5 years
July 2, 2018
February 8, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Manipulation of Valence
Behavioral measure:number of correct responses (correct recall and correct recognition), evoked potential for EEG only for Experiment 1
During the presentation of the stimuli or just after the presentation of the stimuli
Secondary Outcomes (6)
EEG measures
During the presentation of the stimuli or just after the presentation of the stimuli
Source memory
During the presentation of the stimuli or just after the presentation of the stimuli
Content memory
During the presentation of the stimuli or just after the presentation of the stimuli
Spatial memory
During the presentation of the stimuli or just after the presentation of the stimuli
Recognition memory
During the presentation of the stimuli or just after the presentation of the stimuli
- +1 more secondary outcomes
Study Arms (2)
Atypical development
EXPERIMENTAL30 children with Williams-Beuren syndrome will be presented with two tasks of episodic memory, one with visual stimuli and another one with audio-verbal stimuli. Manipulation of valence and modality (negative, positive, neutral) in order to measure influence of emotion on episodic memory:Spatial and recognition memory ans source and content memory. The tasks will be presented one after another with a break of 15 minutes. In both tasks the participants will have to encode the stimuli and then first recall them and second to recognize the encoded stimuli amongst new stimuli. The stimuli will be presented on the computer. The responses will be collected by the experimenter for recall task and by the computer for recognition task. During the recognition task the EEG recording will be done.
Typical development
SHAM COMPARATOR30 control children matched for mental age will be presented with two tasks of episodic memory, one with visual stimuli and another one with audio-verbal stimuli. Manipulation of valence and modality (negative, positive, neutral) in order to measure influence of emotion on episodic memory:Spatial and recognition memory ans source and content memory. The tasks will be presented one after another with a break of 15 minutes. In both tasks the participants will have to encode the stimuli and then first recall them and second to recognize the encoded stimuli amongst new stimuli. The stimuli will be presented on the computer. The responses will be collected by the experimenter for recall task and by the computer for recognition task. During the recognition task the EEG recording will be done.
Interventions
mnemic task with a phase of encoding negative, positive and neutral stimuli, will be proposed followed by an immediate recovery phase, composed of a recall task followed by a recognition task
mnemic task with a phase of encoding negative, positive and neutral stimuli, will be proposed followed by an immediate recovery phase, composed of a recall task followed by a recognition task
mnemic task with a phase of encoding negative, positive and neutral stimuli, will be proposed followed by an immediate recovery phase, composed of a recall task followed by a recognition task
Eligibility Criteria
You may qualify if:
- Children with William-Beuren syndrome
- Genetic diagnosis (CGH-Array or FISH) of microdeletion 7q11.23
- to 18 years old
- Native French speaker
- Typically developing children and healthy adults:
- to 30 years old
- Native French speaker
- Absence of history of neurodevelopmental neurological and psychiatric disease
You may not qualify if:
- Children with William-Beuren syndrome:
- Diagnosis of severe intellectual deficit (Total IQ lower than 40 evaluated with WPPSI-II or WISC-IV)
- Presence of another genetic anomaly
- Presence of vascular; infectious or neurodegenerative disease
- Medication impacting motor and cognitive abilities
- Non-corrected visual and hearing impairment
- Typically developing children and Healthy Adults :
- Diagnosis of severe intellectual deficit (Total IQ lower than 70 evaluated with WPPSI-II or WISC-IV)
- Presence of vascular; infectious or neurodegenerative disease knew by parents or legal representative
- Learning disorders
- History of neurological or psychiatric disease
- Medication impacting motor and cognitive abilities, non-corrected visual and hearing impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hopital Vinatier
Lyon, Auvergne-Rhône-Alpes, 69678, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
DEMILY CAROLINE
CH LE VINATIER
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 2, 2018
First Posted
September 28, 2018
Study Start
June 28, 2018
Primary Completion
December 15, 2020
Study Completion
December 15, 2020
Last Updated
February 9, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share